Form 4: Cardiff Oncology CFO James Levine Reports Beneficial Ownership Changes
SEC Form 4
Cardiff Oncology's CFO, James Levine, reports changes in beneficial ownership of common stock due to purchases made by his wife.
Summary
- James Levine, CFO of Cardiff Oncology, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's common stock.
- The reported transactions involve purchases of common stock by Levine's wife on December 16, 2024, December 17, 2024, and December 18, 2024.
- On December 16, 2024, 2,564 shares were purchased at $3.83 per share.
- On December 17, 2024, 2,752 shares were purchased at $5.4162 per share.
- On December 18, 2024, 2,400 shares were purchased at $5 per share.
- Following these transactions, Levine indirectly owns 67,716 shares of Cardiff Oncology common stock through his wife.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions.
Industry Context
Form 4 filings are a routine part of regulatory compliance for company insiders and provide transparency into their trading activities. These filings are closely watched by investors as they can provide signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may interpret the CFO's wife's stock purchases as a positive signal, indicating confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Purchase of 2,564 shares of common stock at $3.83 per share by James Levine's wife. |
| 12/17/2024 | Purchase of 2,752 shares of common stock at $5.4162 per share by James Levine's wife. |
| 12/18/2024 | Purchase of 2,400 shares of common stock at $5 per share by James Levine's wife and signature date of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.